Document is current

Article History

Received: 11 January 2017

Accepted: 30 October 2017

First Online: 25 November 2017

Ethics approval and consent to participate

: Before the study began, the Institutional Review Boards of all involved institutions, including Boston University, Harvard University, University of Florida, University of Arkansas, Universidad Peruana Cayetano Heredia, Hospital San Juan de Lurigancho, Instituto Nacional de Salud, Stellenbosch University and South African Medicines Control Council, reviewed and approved the study protocol and informed consent documents. The study is being conducted under an investigational new drug (IND) from the US Food and Drug Administration (FDA). A list of the reference numbers for all ethical bodies that approved the study can be found in Additional file InternalRef removed. Patients who meet the inclusion criteria (see Table InternalRef removed) are enrolled via the informed consent process. The approved consent form can be found in Additional file InternalRef removed.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.